Search research articles
Contact Us
Filters
Showing results (451-460 of 476) with videos related to
Page
of 48
Sort By:
The Journal of Antimicrobial Chemotherapy
|
October 5, 2015
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H Abdul-Aziz, Jeffrey Lipman, Murat Akova, et al.
International Journal of Antimicrobial Agents
|
April 23, 2026
Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections
Puteri Juanita Zamri, Saskia A Wölky, Maria P Hernandez-Mitre, et al.
Elife
|
April 28, 2020
A tudor domain protein, SIMR-1, promotes siRNA production at piRNA-targeted mRNAs in <i>C. elegans</i>
Kevin I Manage, Alicia K Rogers, Dylan C Wallis, et al.
Intensive Care Medicine Experimental
|
July 13, 2018
A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models
Jayesh A Dhanani, Jeremy Cohen, Suzanne L Parker, et al.
Scientific Reports
|
October 30, 2025
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment
Helmi Sulaiman, Muhammad Azrai Rozali, Santosh K S Adiraju, et al.
BMC Infectious Diseases
|
March 3, 2016
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients
Jason A Roberts, Gordon Y S Choi, Gavin M Joynt, et al.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against <i>Pseudomonas aeruginosa</i> for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
Jessica R Tait, Hajira Bilal, Kate E Rogers, et al.
International Journal of Antimicrobial Agents
|
March 18, 2014
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study
J A Roberts, V Stove, J J De Waele, et al.
The Journal of Antimicrobial Chemotherapy
|
June 19, 2026
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock
Helmi Sulaiman, Saskia A Wölky, Muhammad Azrai Rozali, et al.
International Journal of Antimicrobial Agents
|
October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Page
of 48
Search research articles
Search
Showing results (451-460 of 476) with videos related to
Sort By:
Page
of 48
The Journal of Antimicrobial Chemotherapy
|
October 5, 2015
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H Abdul-Aziz, Jeffrey Lipman, Murat Akova, et al.
International Journal of Antimicrobial Agents
|
April 23, 2026
Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections
Puteri Juanita Zamri, Saskia A Wölky, Maria P Hernandez-Mitre, et al.
Elife
|
April 28, 2020
A tudor domain protein, SIMR-1, promotes siRNA production at piRNA-targeted mRNAs in <i>C. elegans</i>
Kevin I Manage, Alicia K Rogers, Dylan C Wallis, et al.
Intensive Care Medicine Experimental
|
July 13, 2018
A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models
Jayesh A Dhanani, Jeremy Cohen, Suzanne L Parker, et al.
Scientific Reports
|
October 30, 2025
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment
Helmi Sulaiman, Muhammad Azrai Rozali, Santosh K S Adiraju, et al.
BMC Infectious Diseases
|
March 3, 2016
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients
Jason A Roberts, Gordon Y S Choi, Gavin M Joynt, et al.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against <i>Pseudomonas aeruginosa</i> for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
Jessica R Tait, Hajira Bilal, Kate E Rogers, et al.
International Journal of Antimicrobial Agents
|
March 18, 2014
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study
J A Roberts, V Stove, J J De Waele, et al.
The Journal of Antimicrobial Chemotherapy
|
June 19, 2026
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock
Helmi Sulaiman, Saskia A Wölky, Muhammad Azrai Rozali, et al.
International Journal of Antimicrobial Agents
|
October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Page
of 48